{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:08:21Z","timestamp":1786118901440,"version":"build-2736575974"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1097\/nrl.0b013e318247b868","type":"journal-article","created":{"date-parts":[[2012,2,24]],"date-time":"2012-02-24T04:39:51Z","timestamp":1330058391000},"page":"85-87","source":"Crossref","is-referenced-by-count":19,"title":["Progressive Multifocal Leukoencephalopathy in a Patient Treated With Etanercept"],"prefix":"10.1097","volume":"18","author":[{"given":"Jonathan","family":"Graff-Radford","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maisha T.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahma M.","family":"Warsame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric L.","family":"Matteson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D. Z.","family":"Eggers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. Mark","family":"Keegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210211","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/13550289809113482","article-title":"Progressive multifocal leukoencephalopathy in patients with HIV infection.","volume":"4","author":"Berger","year":"1998","journal-title":"J Neurovirol"},{"key":"R2-9-20210211","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S1474-4422(10)70028-4","article-title":"Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases.","volume":"9","author":"Clifford","year":"2010","journal-title":"Lancet Neurol"},{"key":"R3-9-20210211","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/archdermatol.2009.175","article-title":"Progressive multifocal leukoencephalopathy, efalizumab, and immunosuppression: a cautionary tale for dermatologists.","volume":"145","author":"Korman","year":"2009","journal-title":"Arch Dermatol"},{"key":"R4-9-20210211","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1182\/blood-2008-10-186999","article-title":"Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project.","volume":"113","author":"Carson","year":"2009","journal-title":"Blood"},{"key":"R5-9-20210211","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1002\/1529-0131(200112)44:12<2862::AID-ART474>3.0.CO;2-W","article-title":"Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides.","volume":"44","author":"Mohan","year":"2001","journal-title":"Arthritis Rheum"},{"key":"R6-9-20210211","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1002\/art.27687","article-title":"A case of progressive multifocal leukoencephalopathy in a patient treated with infliximab the University of North Carolina at Chapel Hill.","volume":"62","author":"Kumar","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R7-9-20210211","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3109\/s10165-006-0530-2","article-title":"Leukoencephalopathy during administration of etanercept for refractory rheumatoid arthritis.","volume":"17","author":"Yamamoto","year":"2007","journal-title":"Mod Rheumatol"},{"key":"R8-9-20210211","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/art.21688","article-title":"Anti-tumor necrosis factor alpha therapy and the risk of JC virus infection.","volume":"54","author":"Roos","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R10-9-20210211","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/00000441-200507000-00008","article-title":"T-cell lymphopenia associated with infliximab and cyclophosphamide.","volume":"330","author":"Wachi","year":"2005","journal-title":"Am J Med Sci"},{"key":"R11-9-20210211","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1002\/art.24966","article-title":"Progressive multifocal leukoencephalopathy: a national estimate of frequency in systemic lupus erythematosus and other rheumatic diseases.","volume":"60","author":"Molloy","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R12-9-20210211","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/01.nrl.0000250948.04681.96","article-title":"Review of progressive multifocal leukoencephalopathy and natalizumab.","volume":"12","author":"Aksamit","year":"2006","journal-title":"Neurologist"}],"container-title":["The Neurologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00127893-201203000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:00:19Z","timestamp":1786035619000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00127893-201203000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/nrl.0b013e318247b868","relation":{},"ISSN":["1074-7931"],"issn-type":[{"value":"1074-7931","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}